These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 35091010)

  • 1. Tongxinluo capsule as supplementation and cardiovascular endpoint events in patients with coronary heart disease: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials.
    Lv J; Liu S; Guo S; Gao J; Song Q; Cui X
    J Ethnopharmacol; 2022 May; 289():115033. PubMed ID: 35091010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Different Courses of Tongxinluo Capsule as Adjuvant Therapy for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Hui J; Yuan R; Li P; Xin Q; Miao Y; Shen X; Xu F; Cong W
    J Clin Med; 2022 May; 11(11):. PubMed ID: 35683377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tongxinluo Capsule Combined with Atorvastatin for Coronary Heart Disease: A Systematic Review and Meta-Analysis.
    Liu Q; Dong T; Xi M; Gou L; Bai Y; Hou L; Li M; Ou L; Miao F; Wei P
    Evid Based Complement Alternat Med; 2021; 2021():9413704. PubMed ID: 34335841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A traditional Chinese medicine therapy for coronary heart disease after percutaneous coronary intervention: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Chen R; Xiao Y; Chen M; He J; Huang M; Hong X; Liu X; Fu T; Zhang J; Chen L
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30143584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease.
    Zheng GH; Liu JP; Chu JF; Mei L; Chen HY
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD009581. PubMed ID: 23728695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention.
    Mao C; Fu XH; Yuan JQ; Yang ZY; Chung VC; Qin Y; Huang Y; Tam WW; Kwong JS; Xie W; Tang JL
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD010237. PubMed ID: 25994229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Traditional Chinese Medicine Compound (Tongxinluo) and Clinical Outcomes of Patients With Acute Myocardial Infarction: The CTS-AMI Randomized Clinical Trial.
    Yang Y; Li X; Chen G; Xian Y; Zhang H; Wu Y; Yang Y; Wu J; Wang C; He S; Wang Z; Wang Y; Wang Z; Liu H; Wang X; Zhang M; Zhang J; Li J; An T; Guan H; Li L; Shang M; Yao C; Han Y; Zhang B; Gao R; Peterson ED;
    JAMA; 2023 Oct; 330(16):1534-1545. PubMed ID: 37874574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of tongxinluo capsule for angina pectoris of coronary heart disease: an overview of systematic reviews and meta-analysis.
    Li L; Feng P; Zhou W; Luo B; Deng L; Gan D; Wu X; Zhu F; Zhou X
    Front Cardiovasc Med; 2024; 11():1229299. PubMed ID: 38414926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adjunctive therapy of xuezhikang capsule for coronary heart disease: a systematic review and meta-analysis of randomized controlled trials].
    Wang Y; Chen ZH; Liu GH; Zhang F; Zhang Z; Guan XF; Luo ZB; Yang GL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Oct; 34(10):1182-91. PubMed ID: 25509259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Tongxinluo Capsule as Adjunctive Treatment for Unstable Angina Pectoris: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Li P; Xin Q; Hui J; Yuan R; Wang Y; Miao Y; Lee SM; Leng SX; Cong W;
    Front Pharmacol; 2021; 12():742978. PubMed ID: 34707500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tongxinluo Capsule () for Cardiac Syndrome X: A Systematic Review and Meta-Analysis.
    Mao HM; Liu M; Qu H; Wang LQ; Shi DZ
    Chin J Integr Med; 2018 Apr; 24(4):296-303. PubMed ID: 28819776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tongxinluo (Tong xin luo or Tong-xin-luo) capsule for unstable angina pectoris.
    Wu T; Harrison RA; Chen X; Ni J; Zhou L; Qiao J; Wang Q; Wei J; Xin D; Zheng J
    Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD004474. PubMed ID: 17054205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Chinese Herbal Medicine for Heart Failure with Preserved Ejection Fraction: A Meta-Analysis.
    Mei J; Xu H; Xu FQ; Ju JQ
    Chin J Integr Med; 2019 Oct; 25(10):770-777. PubMed ID: 31127505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Problems with the outcome measures in randomized controlled trials of traditional Chinese medicine in treating chronic heart failure caused by coronary heart disease: a systematic review.
    Hu J; Qiu R; Li C; Li M; Dai Q; Chen S; Zhao C; Shang H
    BMC Complement Med Ther; 2021 Aug; 21(1):217. PubMed ID: 34465313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Exercise after Percutaneous Coronary Intervention on Cardiac Function and Cardiovascular Adverse Events in Patients with Coronary Heart Disease: Systematic Review and Meta-Analysis.
    Zhang H; Chang R
    J Sports Sci Med; 2019 Jun; 18(2):213-222. PubMed ID: 31191090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tongxinluo capsule in combination with conventional therapies for stable angina pectoris: A meta-analysis and systematic review.
    Feng R; Lin Q; Wei D; Li Y; Zhang R; Jiang K; Li Y; Xie L; Xia J; Zheng P; Ji X; Wang W; Qu X; Gao Q; Pan Y; Liu J
    Medicine (Baltimore); 2023 Oct; 102(41):e35405. PubMed ID: 37832041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.
    Sutcliffe P; Connock M; Gurung T; Freeman K; Johnson S; Kandala NB; Grove A; Gurung B; Morrow S; Clarke A
    Health Technol Assess; 2013 Sep; 17(43):1-253. PubMed ID: 24074752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Chinese Medicine on No or Slow Reflow after Percutaneous Coronary Intervention in Myocardial Infarction Patients: A Systematic Review and Meta-Analysis.
    Zhang XY; Sun Y; Yang XY; Hu JY; Zheng R; Chen SQ; Li M; Li CY; Jiang Y; Liu S; Zhao C; Xing YW; Shang HC
    Chin J Integr Med; 2020 Mar; 26(3):227-234. PubMed ID: 31093877
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.